Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes.
暂无分享,去创建一个
[1] H. Beck-Nielsen,et al. On the determination of basal glucose production rate in patients with Type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion , 1990, Diabetologia.
[2] F. Assimacopoulos-Jeannet,et al. Differential effect of steady-state hyperinsulinaemia and hyperglycaemia on hepatic glycogenolysis and glycolysis in rats , 1987, Diabetologia.
[3] R. Rizza,et al. Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans. , 2003, Diabetes.
[4] R. Rizza,et al. Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles. , 2003, American journal of physiology. Endocrinology and metabolism.
[5] J. Radziuk,et al. Quantitation of basal endogenous glucose production in Type II diabetes: importance of the volume of distribution , 2002, Diabetologia.
[6] M. Mozzoli,et al. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. , 2002, American journal of physiology. Endocrinology and metabolism.
[7] I. Gabriely,et al. Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects. , 2002, Diabetes.
[8] C. Chu,et al. Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs. , 2002, American journal of physiology. Endocrinology and metabolism.
[9] K. Nair,et al. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. , 2002, Diabetes.
[10] E. Ferrannini,et al. Determination of the enrichment of the hydrogen bound to carbon 5 of glucose on 2H2O administration. , 2001, Analytical biochemistry.
[11] B. Landau. Methods for measuring glycogen cycling. , 2001, American journal of physiology. Endocrinology and metabolism.
[12] L. Rossetti,et al. Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism. , 2001, Diabetes.
[13] J. Radziuk,et al. Production and metabolic clearance of glucose under basal conditions in Type II (non-insulin-dependent) diabetes mellitus , 2001, Diabetologia.
[14] E. Ferrannini,et al. Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. , 2001, Diabetes.
[15] M. Jensen,et al. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. , 2001, Diabetes.
[16] M. Mozzoli,et al. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. , 2001, Diabetes.
[17] T P Stein,et al. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. , 2001, American journal of physiology. Endocrinology and metabolism.
[18] R. Bergman,et al. Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin. , 2000, American journal of physiology. Endocrinology and metabolism.
[19] E. Ferrannini,et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. , 2000, Diabetes.
[20] G. Shulman,et al. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. , 2000, Diabetes.
[21] C Cobelli,et al. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake. , 1998, Diabetes.
[22] M. Vranic,et al. Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans. , 1998, The American journal of physiology.
[23] K. Petersen,et al. Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. , 1998, The Journal of clinical investigation.
[24] J. Wahren,et al. Quantifying gluconeogenesis during fasting. , 1997, American journal of physiology. Endocrinology and metabolism.
[25] E. Volpi,et al. Evidence of Increased Systemic Glucose Production and Gluconeogenesis in an Early Stage of NIDDM , 1997, Diabetes.
[26] C Cobelli,et al. Impaired Basal Glucose Effectiveness in NIDDM: Contribution of Defects in Glucose Disappearance and Production, Measured Using an Optimized Minimal Model Independent Protocol , 1997, Diabetes.
[27] C. Chu,et al. The Role of Fatty Acids in Mediating the Effects of Peripheral Insulin on Hepatic Glucose Production in the Conscious Dog , 1997, Diabetes.
[28] M. Vranic,et al. Normal hepatic insulin sensitivity in lean, mild noninsulin-dependent diabetic patients. , 1996, The Journal of clinical endocrinology and metabolism.
[29] J. Wahren,et al. Contributions of gluconeogenesis to glucose production in the fasted state. , 1996, The Journal of clinical investigation.
[30] H. Gin,et al. Measurement of post‐absorptive glucose kinetics in non‐insulin‐dependent diabetic patients: methodological aspects , 1996, European journal of clinical investigation.
[31] G. Boden,et al. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. , 1995, The Journal of clinical investigation.
[32] W. Sheu,et al. Relationship Between Hepatic Glucose Production and Fasting Plasma Glucose Concentration in Patients With NIDDM , 1994, Diabetes.
[33] F. Féry. Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes: normalization of glucose kinetics by short-term fasting. , 1994, The Journal of clinical endocrinology and metabolism.
[34] E. Barrett,et al. Insulin and glucose suppress hepatic glycogenolysis by distinct enzymatic mechanisms. , 1993, Metabolism: clinical and experimental.
[35] N. Barzilai,et al. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. , 1993, The Journal of clinical investigation.
[36] R. Shulman,et al. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. , 1992, The Journal of clinical investigation.
[37] H. Beck-Nielsen,et al. Insulin resistance, but normal basal rates of glucose production in patients with newly diagnosed mild diabetes mellitus. , 1991, Acta endocrinologica.
[38] L. Groop,et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.
[39] B. Hansen,et al. Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys. , 1989, The American journal of physiology.
[40] R. DeFronzo,et al. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. , 1989, Metabolism: clinical and experimental.
[41] G. Brechtel,et al. Effects of Fasting on Plasma Glucose and Prolonged Tracer Measurement of Hepatic Glucose Output in NIDDM , 1987, Diabetes.
[42] N. Abumrad,et al. Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivo. , 1987, Diabetes/metabolism reviews.
[43] R. Rizza,et al. Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus. , 1986, The New England journal of medicine.
[44] R. Rizza,et al. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. , 1986, The Journal of clinical investigation.
[45] R. DeFronzo,et al. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. , 1985, The Journal of clinical investigation.
[46] B V Howard,et al. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. , 1984, The Journal of clinical investigation.
[47] E. Rayfield,et al. Transhepatic glucagon gradients in man: evidence for glucagon extraction by human liver. , 1984, The Journal of clinical endocrinology and metabolism.
[48] J. Thiessen,et al. High-pressure liquid chromatographic analysis of indocyanine green. , 1982, Journal of pharmaceutical sciences.
[49] J. A. Scarlett,et al. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. , 1981, The Journal of clinical investigation.
[50] L. Mandarino,et al. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. , 1981, The American journal of physiology.
[51] G. Shulman,et al. Differential Time Course of Glucagon's Effect on Glycogenolysis and Gluconeogenesis in the Conscious Dog , 1981, Diabetes.
[52] K. Tranberg. Hepatic uptake of insulin in man. , 1979, The American journal of physiology.
[53] W. Blackard,et al. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. , 1975, The Journal of clinical investigation.
[54] W. Blackard,et al. Portal and Peripheral Vein Immunoreactive Glucagon Concentrations After Arginine or Glucose Infusions , 1974, Diabetes.
[55] R. Steele,et al. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. , 1956, The American journal of physiology.
[56] 박귀태,et al. A Type 2 Diabetes–Associated Functional Regulatory Variant in a Pancreatic Islet Enhancer at the ADCY5 Locus , 2017, Diabetes.